Advanced Biomed Inc stock is traded at $2.26, with a volume of 8,634. It is down -10.67% in the last 24 hours and down -43.22% over the past month. Advanced Biomed Inc operates through its subsidiaries and is mainly engaged in the research and development of various original microfluidic biochip technologies and the provision of tumor precision diagnosis and treatment technology applications. Through the joint application of semiconductor technology and biotechnology, it has developed various technologies and testing equipment for early screening and detection, diagnosis and staging, and treatment of cancer. Its devices: A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip, and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
Previous Close:
$2.53
Open:
$2.49
24h Volume:
8,634
Relative Volume:
0.07
Market Cap:
$3.73M
Revenue:
-
Net Income/Loss:
$174.50K
P/E Ratio:
14.20
EPS:
$0.1592
Net Cash Flow:
-$102.70K
1W Performance:
+10.24%
1M Performance:
-43.22%
6M Performance:
-48.64%
1Y Performance:
-74.12%
1-Day Range:
$2.26$2.49
1-Week Range:
$1.98$3.95
52-Week Range:
$1.80$24.23
Advanced Biomed Inc Stock (ADVB) Company Profile
Name
Advanced Biomed IncSector
HealthcareIndustry
Diagnostics & ResearchPhone
86-21-20510823Address
401 RYLAND ST, RENO, TaiwanMarket Cap
Revenue
Net Income
Cash Flow
EPS